Shenzhen Majory Biotechnology Co., Ltd.

This study is testing a new drug called MR001, given alongside standard chemotherapy, for people with advanced pancreatic cancer that has gotten worse after their first treatment. The main goals are to find a safe dose of MR001 and to get an early look at whether the combination …

This study is testing a new drug called MR001 for people with advanced triple-negative breast cancer that has continued to grow despite previous treatments. The main goals are to find a safe dose and see how the body processes the drug. Researchers will also look for early signs …